Published in J Struct Biol on March 17, 2011
Poxviruses deploy genomic accordions to adapt rapidly against host antiviral defenses. Cell (2012) 2.94
Host factor SAMHD1 restricts DNA viruses in non-dividing myeloid cells. PLoS Pathog (2013) 1.37
Viral modulation of programmed necrosis. Curr Opin Virol (2013) 1.20
Poxvirus targeting of E3 ligase β-TrCP by molecular mimicry: a mechanism to inhibit NF-κB activation and promote immune evasion and virulence. PLoS Pathog (2013) 1.08
Subversion of cytokine networks by virally encoded decoy receptors. Immunol Rev (2012) 0.98
Myxoma virus protein M029 is a dual function immunomodulator that inhibits PKR and also conscripts RHA/DHX9 to promote expanded host tropism and viral replication. PLoS Pathog (2013) 0.97
Vaccinia virus F1L protein promotes virulence by inhibiting inflammasome activation. Proc Natl Acad Sci U S A (2013) 0.97
Mapping the IkappaB kinase beta (IKKbeta)-binding interface of the B14 protein, a vaccinia virus inhibitor of IKKbeta-mediated activation of nuclear factor kappaB. J Biol Chem (2011) 0.97
Systems kinomics demonstrates Congo Basin monkeypox virus infection selectively modulates host cell signaling responses as compared to West African monkeypox virus. Mol Cell Proteomics (2011) 0.92
Cells under siege: viral glycoprotein interactions at the cell surface. J Struct Biol (2011) 0.91
Vaccinia virus protein N2 is a nuclear IRF3 inhibitor that promotes virulence. J Gen Virol (2013) 0.90
Vaccinia virus protein K7 is a virulence factor that alters the acute immune response to infection. J Gen Virol (2013) 0.86
Vaccinia virus inhibits NF-κB-dependent gene expression downstream of p65 translocation. J Virol (2013) 0.85
The vaccinia virus-encoded Bcl-2 homologues do not act as direct Bax inhibitors. J Virol (2011) 0.84
Characterization and structure of the vaccinia virus NF-κB antagonist A46. J Biol Chem (2013) 0.82
In vitro inhibition of monkeypox virus production and spread by Interferon-β. Virol J (2012) 0.81
Lister strain vaccinia virus with thymidine kinase gene deletion is a tractable platform for development of a new generation of oncolytic virus. Gene Ther (2015) 0.80
Genomic variability of monkeypox virus among humans, Democratic Republic of the Congo. Emerg Infect Dis (2014) 0.80
Cytokine production associated with smallpox vaccine responses. Immunotherapy (2014) 0.78
Predictive and Prognostic Clinical Variables in Cancer Patients Treated With Adenoviral Oncolytic Immunotherapy. Mol Ther (2016) 0.77
Structural Conservation and Functional Diversity of the Poxvirus Immune Evasion (PIE) Domain Superfamily. Viruses (2015) 0.77
Structure of vaccinia virus A46, an inhibitor of TLR4 signaling pathway, shows the conformation of VIPER motif. Protein Sci (2014) 0.76
Vaccinia Virus Immunomodulator A46: A Lipid and Protein-Binding Scaffold for Sequestering Host TIR-Domain Proteins. PLoS Pathog (2016) 0.75
Virus-encoded ectopic CD74 enhances poxvirus vaccine efficacy. Immunology (2014) 0.75
Both CD8+ and CD4+ T Cells Contribute to Corneal Clouding and Viral Clearance following Vaccinia Virus Infection in C57BL/6 Mice. J Virol (2016) 0.75
IL-1R Type 1-Deficient Mice Demonstrate an Impaired Host Immune Response against Cutaneous Vaccinia Virus Infection. J Immunol (2017) 0.75
Pathogen recognition and innate immunity. Cell (2006) 44.14
The Pfam protein families database. Nucleic Acids Res (2007) 30.53
Shared principles in NF-kappaB signaling. Cell (2008) 20.96
The BCL-2 protein family: opposing activities that mediate cell death. Nat Rev Mol Cell Biol (2008) 20.89
Stats: transcriptional control and biological impact. Nat Rev Mol Cell Biol (2002) 15.33
Chemokines: a new classification system and their role in immunity. Immunity (2000) 13.03
The TNF and TNF receptor superfamilies: integrating mammalian biology. Cell (2001) 12.59
The many roles of chemokines and chemokine receptors in inflammation. N Engl J Med (2006) 10.99
Signalling pathways of the TNF superfamily: a double-edged sword. Nat Rev Immunol (2003) 10.29
Signaling to NF-kappaB by Toll-like receptors. Trends Mol Med (2007) 6.52
NF-kappaB and the immune response. Oncogene (2006) 5.62
Chemokines in innate and adaptive host defense: basic chemokinese grammar for immune cells. Annu Rev Immunol (2004) 5.07
Poxviruses and immune evasion. Annu Rev Immunol (2001) 4.80
Bax in murine thymus is a soluble monomeric protein that displays differential detergent-induced conformations. J Biol Chem (1998) 4.71
Viruses and apoptosis. Annu Rev Microbiol (1999) 4.24
Impact of protein kinase PKR in cell biology: from antiviral to antiproliferative action. Microbiol Mol Biol Rev (2006) 4.13
A46R and A52R from vaccinia virus are antagonists of host IL-1 and toll-like receptor signaling. Proc Natl Acad Sci U S A (2000) 3.69
Structural biology of the Bcl-2 family of proteins. Biochim Biophys Acta (2004) 3.47
The structure of a Bcl-xL/Bim fragment complex: implications for Bim function. Immunity (2003) 3.19
Cell damage-induced conformational changes of the pro-apoptotic protein Bak in vivo precede the onset of apoptosis. J Cell Biol (1999) 3.18
In a nutshell: structure and assembly of the vaccinia virion. Adv Virus Res (2006) 3.17
Viral mimicry of cytokines, chemokines and their receptors. Nat Rev Immunol (2003) 3.16
What does structure tell us about virus evolution? Curr Opin Struct Biol (2005) 3.02
The poxvirus protein A52R targets Toll-like receptor signaling complexes to suppress host defense. J Exp Med (2003) 2.85
Viral mechanisms of immune evasion. Immunol Today (2000) 2.74
Induction of apoptosis by the dsRNA-dependent protein kinase (PKR): mechanism of action. Apoptosis (2000) 2.63
Vaccinia virus-encoded eIF-2 alpha homolog abrogates the antiviral effect of interferon. Virology (1991) 2.63
Viral targeting of DEAD box protein 3 reveals its role in TBK1/IKKepsilon-mediated IRF activation. EMBO J (2008) 2.53
Poxvirus genomes: a phylogenetic analysis. J Gen Virol (2004) 2.40
Poxvirus protein N1L targets the I-kappaB kinase complex, inhibits signaling to NF-kappaB by the tumor necrosis factor superfamily of receptors, and inhibits NF-kappaB and IRF3 signaling by toll-like receptors. J Biol Chem (2004) 2.21
Semaphorins and their receptors in immune cell interactions. Nat Immunol (2007) 2.07
Recombinant vaccinia virus K3L gene product prevents activation of double-stranded RNA-dependent, initiation factor 2 alpha-specific protein kinase. J Biol Chem (1993) 2.04
Nucleotide sequence of 42 kbp of vaccinia virus strain WR from near the right inverted terminal repeat. J Gen Virol (1991) 1.96
Genome sequence diversity and clues to the evolution of variola (smallpox) virus. Science (2006) 1.84
Vaccinia virus anti-apoptotic F1L is a novel Bcl-2-like domain-swapped dimer that binds a highly selective subset of BH3-containing death ligands. Cell Death Differ (2008) 1.80
Functional and structural studies of the vaccinia virus virulence factor N1 reveal a Bcl-2-like anti-apoptotic protein. J Gen Virol (2007) 1.73
The interferon system and vaccinia virus evasion mechanisms. J Interferon Cytokine Res (2009) 1.67
Inhibition of IkappaB kinase by vaccinia virus virulence factor B14. PLoS Pathog (2008) 1.63
Proapoptotic BH3-only proteins trigger membrane integration of prosurvival Bcl-w and neutralize its activity. J Cell Biol (2003) 1.60
The structure of Bcl-w reveals a role for the C-terminal residues in modulating biological activity. EMBO J (2003) 1.59
Vaccinia virus blocks gamma interferon signal transduction: viral VH1 phosphatase reverses Stat1 activation. J Virol (2001) 1.59
Vaccinia virus proteins A52 and B14 Share a Bcl-2-like fold but have evolved to inhibit NF-kappaB rather than apoptosis. PLoS Pathog (2008) 1.57
The vaccinia virus N1L protein is an intracellular homodimer that promotes virulence. J Gen Virol (2002) 1.57
A structural viral mimic of prosurvival Bcl-2: a pivotal role for sequestering proapoptotic Bax and Bak. Mol Cell (2007) 1.47
Vaccinia virus N1L protein resembles a B cell lymphoma-2 (Bcl-2) family protein. Protein Sci (2006) 1.45
Evasion of innate immunity by vaccinia virus. Parasitology (2005) 1.42
The myxoma poxvirus protein, M11L, prevents apoptosis by direct interaction with the mitochondrial permeability transition pore. J Exp Med (2002) 1.39
Host-related immunomodulators encoded by poxviruses and herpesviruses. Curr Opin Microbiol (2000) 1.38
Structural basis of semaphorin-plexin recognition and viral mimicry from Sema7A and A39R complexes with PlexinC1. Cell (2010) 1.35
Structure of a soluble secreted chemokine inhibitor vCCI (p35) from cowpox virus. Proc Natl Acad Sci U S A (1999) 1.29
Near death experiences: poxvirus regulation of apoptotic death. Virology (2006) 1.27
Poxviruses: past, present and future. Virus Res (2006) 1.26
Solution of the structure of the TNF-TNFR2 complex. Sci Signal (2010) 1.25
Deletion of gene A41L enhances vaccinia virus immunogenicity and vaccine efficacy. J Gen Virol (2006) 1.25
Poxvirus K7 protein adopts a Bcl-2 fold: biochemical mapping of its interactions with human DEAD box RNA helicase DDX3. J Mol Biol (2008) 1.22
X-ray crystal structure and functional analysis of vaccinia virus K3L reveals molecular determinants for PKR subversion and substrate recognition. Mol Cell (2002) 1.18
Poxviruses and apoptosis: a time to die. Curr Opin Microbiol (2002) 1.17
Viral Bcl-2 homologs and their role in virus replication and associated diseases. Biochim Biophys Acta (2004) 1.14
Structural basis for antagonism of human interleukin 18 by poxvirus interleukin 18-binding protein. Proc Natl Acad Sci U S A (2008) 1.13
Modified vaccinia virus Ankara protein F1L is a novel BH3-domain-binding protein and acts together with the early viral protein E3L to block virus-associated apoptosis. Cell Death Differ (2006) 1.11
Structure of M11L: A myxoma virus structural homolog of the apoptosis inhibitor, Bcl-2. Protein Sci (2007) 1.11
Regulation of apoptosis: uncovering the binding determinants. Curr Opin Struct Biol (2005) 1.10
Vaccinia virus F1L protein is a tail-anchored protein that functions at the mitochondria to inhibit apoptosis. J Virol (2005) 1.08
Solution structure of the complex between poxvirus-encoded CC chemokine inhibitor vCCI and human MIP-1beta. Proc Natl Acad Sci U S A (2006) 1.08
CrmE, a novel soluble tumor necrosis factor receptor encoded by poxviruses. J Virol (2001) 1.07
Virus subversion of immunity: a structural perspective. Curr Opin Immunol (2001) 1.06
The vaccinia virus A41L protein is a soluble 30 kDa glycoprotein that affects virus virulence. J Gen Virol (2001) 1.04
Structure and function of A41, a vaccinia virus chemokine binding protein. PLoS Pathog (2008) 1.04
Structure of CrmE, a virus-encoded tumour necrosis factor receptor. J Mol Biol (2007) 1.03
A secreted high-affinity inhibitor of human TNF from Tanapox virus. Proc Natl Acad Sci U S A (2003) 1.02
Structural basis for targeting of human RNA helicase DDX3 by poxvirus protein K7. Structure (2009) 1.01
Vaccinia virus blocks Stat1-dependent and Stat1-independent gene expression induced by type I and type II interferons. J Interferon Cytokine Res (2008) 0.99
Structural determinants of chemokine binding by an Ectromelia virus-encoded decoy receptor. J Virol (2006) 0.96
Dimeric quaternary structure of the prototypical dual specificity phosphatase VH1. J Biol Chem (2009) 0.96
An ectromelia virus protein that interacts with chemokines through their glycosaminoglycan binding domain. J Virol (2007) 0.96
Tumor necrosis factor receptors encoded by poxviruses. Mol Genet Metab (1999) 0.93
Role of genes that modulate host immune responses in the immunogenicity and pathogenicity of vaccinia virus. J Virol (2005) 0.92
Crystal structure of TNFalpha complexed with a poxvirus MHC-related TNF binding protein. Nat Struct Mol Biol (2009) 0.90
Structure and mechanism of IFN-gamma antagonism by an orthopoxvirus IFN-gamma-binding protein. Proc Natl Acad Sci U S A (2008) 0.90
Historical developments in the research of interferon receptors. Cytokine Growth Factor Rev (2007) 0.87
Fitness cost of escape mutations in p24 Gag in association with control of human immunodeficiency virus type 1. J Virol (2006) 6.30
Enhanced T-cell immunogenicity of plasmid DNA vaccines boosted by recombinant modified vaccinia virus Ankara in humans. Nat Med (2003) 4.64
Memory T cells established by seasonal human influenza A infection cross-react with avian influenza A (H5N1) in healthy individuals. J Clin Invest (2008) 4.30
Protein production and purification. Nat Methods (2008) 3.97
Structural basis for the recognition of hydroxyproline in HIF-1 alpha by pVHL. Nature (2002) 3.78
A procedure for setting up high-throughput nanolitre crystallization experiments. Crystallization workflow for initial screening, automated storage, imaging and optimization. Acta Crystallogr D Biol Crystallogr (2005) 3.75
A versatile ligation-independent cloning method suitable for high-throughput expression screening applications. Nucleic Acids Res (2007) 3.22
A structural basis for immunodominant human T cell receptor recognition. Nat Immunol (2003) 3.15
Lysine methylation as a routine rescue strategy for protein crystallization. Structure (2006) 3.14
Towards rationalization of crystallization screening for small- to medium-sized academic laboratories: the PACT/JCSG+ strategy. Acta Crystallogr D Biol Crystallogr (2005) 3.13
What does structure tell us about virus evolution? Curr Opin Struct Biol (2005) 3.02
The poxvirus protein A52R targets Toll-like receptor signaling complexes to suppress host defense. J Exp Med (2003) 2.85
A sensor-adaptor mechanism for enterovirus uncoating from structures of EV71. Nat Struct Mol Biol (2012) 2.81
Vaccinia virus protein A46R targets multiple Toll-like-interleukin-1 receptor adaptors and contributes to virulence. J Exp Med (2005) 2.66
Structural basis of Nipah and Hendra virus attachment to their cell-surface receptor ephrin-B2. Nat Struct Mol Biol (2008) 2.58
Insights into assembly from structural analysis of bacteriophage PRD1. Nature (2004) 2.47
Crystal structure of a soluble CD28-Fab complex. Nat Immunol (2005) 2.46
The interaction properties of costimulatory molecules revisited. Immunity (2002) 2.43
A mechanical explanation of RNA pseudoknot function in programmed ribosomal frameshifting. Nature (2006) 2.41
Bluetongue virus VP4 is an RNA-capping assembly line. Nat Struct Mol Biol (2007) 2.40
Poxvirus genomes: a phylogenetic analysis. J Gen Virol (2004) 2.40
Glycoprotein structural genomics: solving the glycosylation problem. Structure (2007) 2.40
A functional and structural basis for TCR cross-reactivity in multiple sclerosis. Nat Immunol (2002) 2.31
Detection of a fourth orbivirus non-structural protein. PLoS One (2011) 2.11
The postfusion structure of baculovirus gp64 supports a unified view of viral fusion machines. Nat Struct Mol Biol (2008) 2.09
Structure of the integrin binding fragment from fibrillin-1 gives new insights into microfibril organization. Structure (2004) 1.97
The structure of an RNAi polymerase links RNA silencing and transcription. PLoS Biol (2006) 1.96
In situ macromolecular crystallography using microbeams. Acta Crystallogr D Biol Crystallogr (2012) 1.94
Structure and functionality in flavivirus NS-proteins: perspectives for drug design. Antiviral Res (2009) 1.87
Insights into the evolution of a complex virus from the crystal structure of vaccinia virus D13. Structure (2011) 1.86
Atomic snapshots of an RNA packaging motor reveal conformational changes linking ATP hydrolysis to RNA translocation. Cell (2004) 1.86
Genome sequence diversity and clues to the evolution of variola (smallpox) virus. Science (2006) 1.84
Long-term persistence of a polyclonal T cell repertoire after gene therapy for X-linked severe combined immunodeficiency. Sci Transl Med (2011) 1.81
Hematopoietic stem cell gene therapy for adenosine deaminase-deficient severe combined immunodeficiency leads to long-term immunological recovery and metabolic correction. Sci Transl Med (2011) 1.81
Endocytic tubules regulated by Rab GTPases 5 and 11 are used for envelopment of herpes simplex virus. EMBO J (2012) 1.75
Functional and structural studies of the vaccinia virus virulence factor N1 reveal a Bcl-2-like anti-apoptotic protein. J Gen Virol (2007) 1.73
Vaccinia virus morphogenesis and dissemination. Trends Microbiol (2008) 1.73
Entry of the vaccinia virus intracellular mature virion and its interactions with glycosaminoglycans. J Gen Virol (2005) 1.70
Paired receptor specificity explained by structures of signal regulatory proteins alone and complexed with CD47. Mol Cell (2008) 1.68
The ligand-binding face of the semaphorins revealed by the high-resolution crystal structure of SEMA4D. Nat Struct Biol (2003) 1.68
The molecular basis for the endocytosis of small R-SNAREs by the clathrin adaptor CALM. Cell (2011) 1.66
Quantification of antibody responses against multiple antigens of the two infectious forms of Vaccinia virus provides a benchmark for smallpox vaccination. Nat Med (2006) 1.64
Inhibition of IkappaB kinase by vaccinia virus virulence factor B14. PLoS Pathog (2008) 1.63
An in-depth analysis of original antigenic sin in dengue virus infection. J Virol (2010) 1.63
Ligand-induced and nonfusogenic dissolution of a viral membrane. Proc Natl Acad Sci U S A (2006) 1.62
Antibody-sensitive and antibody-resistant cell-to-cell spread by vaccinia virus: role of the A33R protein in antibody-resistant spread. J Gen Virol (2002) 1.59
Structure unifies the viral universe. Annu Rev Biochem (2012) 1.58
Picornavirus uncoating intermediate captured in atomic detail. Nat Commun (2013) 1.57
Vaccinia virus proteins A52 and B14 Share a Bcl-2-like fold but have evolved to inhibit NF-kappaB rather than apoptosis. PLoS Pathog (2008) 1.57
The vaccinia virus N1L protein is an intracellular homodimer that promotes virulence. J Gen Virol (2002) 1.57
The nsp9 replicase protein of SARS-coronavirus, structure and functional insights. Structure (2004) 1.55
DNA-PK is a DNA sensor for IRF-3-dependent innate immunity. Elife (2012) 1.53
Membrane structure and interactions with protein and DNA in bacteriophage PRD1. Nature (2004) 1.53
Murine interferon lambdas (type III interferons) exhibit potent antiviral activity in vivo in a poxvirus infection model. J Gen Virol (2005) 1.52
Implications of the HIV-1 Rev dimer structure at 3.2 A resolution for multimeric binding to the Rev response element. Proc Natl Acad Sci U S A (2010) 1.51
Evolution of viral structure. Theor Popul Biol (2002) 1.48
How baculovirus polyhedra fit square pegs into round holes to robustly package viruses. EMBO J (2009) 1.46
The Protein Information Management System (PiMS): a generic tool for any structural biology research laboratory. Acta Crystallogr D Biol Crystallogr (2011) 1.45
An investigation of the therapeutic value of vaccinia-immune IgG in a mouse pneumonia model. J Gen Virol (2005) 1.45
A kinetic analysis of immune mediators in the lungs of mice infected with vaccinia virus and comparison with intradermal infection. J Gen Virol (2003) 1.43
The vaccinia virus F12L protein is associated with intracellular enveloped virus particles and is required for their egress to the cell surface. J Gen Virol (2002) 1.38
Insights into virus evolution and membrane biogenesis from the structure of the marine lipid-containing bacteriophage PM2. Mol Cell (2008) 1.37
Evolution of complex RNA polymerases: the complete archaeal RNA polymerase structure. PLoS Biol (2009) 1.36
Dermal infection with vaccinia virus reveals roles for virus proteins not seen using other inoculation routes. J Gen Virol (2002) 1.36
PCNA directs type 2 RNase H activity on DNA replication and repair substrates. Nucleic Acids Res (2011) 1.35
Vaccinia virus interleukin-18-binding protein promotes virulence by reducing gamma interferon production and natural killer and T-cell activity. J Virol (2003) 1.34
The sequence of camelpox virus shows it is most closely related to variola virus, the cause of smallpox. J Gen Virol (2002) 1.33
Vaccinia virus cores are transported on microtubules. J Gen Virol (2003) 1.33
Crystal structure and carbohydrate analysis of Nipah virus attachment glycoprotein: a template for antiviral and vaccine design. J Virol (2008) 1.32
Structure and binding kinetics of three different human CD1d-alpha-galactosylceramide-specific T cell receptors. J Exp Med (2006) 1.32
Outrunning free radicals in room-temperature macromolecular crystallography. Acta Crystallogr D Biol Crystallogr (2012) 1.32
A study of the vaccinia virus interferon-gamma receptor and its contribution to virus virulence. J Gen Virol (2002) 1.30